Beximco Pharmaceuticals Statistics

Total Valuation

AIM:BXP has a market cap or net worth of GBP 222.53 million. The enterprise value is 269.97 million.

Market Cap	222.53M
Enterprise Value	269.97M

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Nov 22, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	311.68M

Valuation Ratios

The trailing PE ratio is 5.25.

PE Ratio	5.25
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.92, with an EV/FCF ratio of 9.88.

EV / Earnings	6.37
EV / Sales	0.90
EV / EBITDA	3.92
EV / EBIT	4.72
EV / FCF	9.88

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.12.

Current Ratio	2.13
Quick Ratio	0.60
Debt / Equity	0.12
Debt / EBITDA	0.58
Debt / FCF	1.51
Interest Coverage	8.48

Financial Efficiency

Return on equity (ROE) is 12.45% and return on invested capital (ROIC) is 9.45%.

Return on Equity (ROE)	12.45%
Return on Assets (ROA)	7.62%
Return on Invested Capital (ROIC)	9.45%
Return on Capital Employed (ROCE)	14.13%
Revenue Per Employee	275,501
Profits Per Employee	37,772
Employee Count	1,122
Asset Turnover	0.64
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.75%
50-Day Moving Average	38.11
200-Day Moving Average	34.37
Relative Strength Index (RSI)	58.57
Average Volume (20 Days)	172,513

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:BXP had revenue of GBP 309.11 million and earned 42.38 million in profits. Earnings per share was 0.09.

Revenue	309.11M
Gross Profit	137.30M
Operating Income	58.70M
Pretax Income	54.79M
Net Income	42.38M
EBITDA	70.08M
EBIT	58.70M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 19.03 million in cash and 41.31 million in debt, giving a net cash position of -22.28 million.

Cash & Cash Equivalents	19.03M
Total Debt	41.31M
Net Cash	-22.28M
Net Cash Per Share	n/a
Equity (Book Value)	357.72M
Book Value Per Share	0.74
Working Capital	87.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 44.23 million and capital expenditures -16.92 million, giving a free cash flow of 27.31 million.

Operating Cash Flow	44.23M
Capital Expenditures	-16.92M
Free Cash Flow	27.31M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 44.42%, with operating and profit margins of 18.99% and 13.71%.

Gross Margin	44.42%
Operating Margin	18.99%
Pretax Margin	17.73%
Profit Margin	13.71%
EBITDA Margin	22.67%
EBIT Margin	18.99%
FCF Margin	8.84%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.02
Dividend Yield	0.05%
Dividend Growth (YoY)	0.44%
Years of Dividend Growth	1
Payout Ratio	24.96%
Buyback Yield	n/a
Shareholder Yield	0.05%
Earnings Yield	19.04%
FCF Yield	12.27%

Dividend Details

Stock Splits

The last stock split was on November 23, 2020. It was a forward split with a ratio of 1.1.

Last Split Date	Nov 23, 2020
Split Type	Forward
Split Ratio	1.1

Scores

AIM:BXP has an Altman Z-Score of 3.32.

Altman Z-Score	3.32
Piotroski F-Score	n/a